Medipal Holdings×Alfresa Holdings
Different ways of making money, on the same scale.
Same yardstick
| Metric | Medipal HoldingsFY ending Mar 2026 | Alfresa HoldingsFY ending Mar 2026 |
|---|---|---|
| Revenue | ¥3.82T | ¥3.1T |
| COGS ratio | 93.2% | 93.0% |
| Operating margin | 1.4% | 1.2% |
| Net margin | 1.1% | 1.3% |
| FCF margin | 1.0% | 0.3% |
Highlighted = best value for that metric
Compare industry percentiles by axis
Each row uses the same 0–100 scale. Dots show each company's rank within its primary industry.
- Medipal HoldingsPrimary industry: Specialty Trading & Wholesale
- Alfresa HoldingsPrimary industry: Specialty Trading & Wholesale
CompanyRank
Revenue growth
- Medipal Holdings32.7179 peers
- Alfresa Holdings33.2179 peers
- Medipal Holdings
Profitability
- Medipal Holdings21.4185 peers
- Alfresa Holdings14.9185 peers
- Medipal Holdings
Cash conversion
- Medipal Holdings42.2179 peers
- Alfresa Holdings56.1179 peers
- Medipal Holdings
Efficiency
- Medipal Holdings77185 peers
- Alfresa Holdings79.2185 peers
- Medipal Holdings
Financial strength
- Medipal HoldingsN/A
- Alfresa HoldingsN/A
- Medipal Holdings
Each dot is a company's percentile within its primary industry; peer groups may differ. Missing axes are labeled as unavailable. No combined score is calculated, and industry rank is not an investment recommendation.
Money flows side by side
Chart height is proportional to revenue.
Medipal Holdings¥3.82T · keeps ¥1 per ¥100
Alfresa Holdings¥3.1T · keeps ¥1 per ¥100
Analyze this page with AI
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.